BET protein inhibitor JQ1 downregulates chromatin accessibility and suppresses metastasis of gastric cancer via inactivating RUNX2/NID1 signaling. Oncogenesis, 2020 Mar 10;9(3):33
Development and validation of a real-time artificial intelligence-assisted system for detecting early gastric cancer: A multicentre retrospective diagnostic study. EBioMedicine,2020 Nov 27;62:103146
ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism. Frontiers in Oncology, 2020 Jun 16;10:915
m6A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1. Frontiers in Oncology, 2020 Sep 29;10:553045
METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut, 2020 Jul;69(7):1193-1205
Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma. American Journal of Cancer Research, 2019 Mar 1;9(3):546-561
Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression. Cancer Letters,2019 Jun 28;452:23-30
CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263. Cell Death and Disease, 2019 Aug 9;10(8):602.
SIRT1 inhibits gastric cancer proliferation and metastasis via STAT3/MMP-13 signaling. Journal of Cellular Physiology, 2019 Feb 2;234(9):15395-15406
The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming. Neoplasia, 2019 May;21(5):429-441